Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides.
暂无分享,去创建一个
A. Higashi | N. Higashi | M. Taniguchi | H. Mita | K. Arimura | K. Akiyama | S. Tohma | Y. Ozawa | Naomi Turikisawa | Ai Higashi
[1] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.
[2] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). , 2010, Arthritis and rheumatism.
[3] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.
[4] A. Higashi,et al. Urinary 3‐bromotyrosine and 3‐chlorotyrosine concentrations in asthmatic patients: lack of increase in 3‐bromotyrosine concentration in urine and plasma proteins in aspirin‐induced asthma after intravenous aspirin challenge , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[5] M. Sanak,et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. , 2004, The Journal of allergy and clinical immunology.
[6] A. Higashi,et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. , 2004, The Journal of allergy and clinical immunology.
[7] H. Er,et al. Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: Is it a new urinary activity marker? , 2003, Nephrology.
[8] C. Rice-Evans,et al. Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine. , 2003, The Biochemical journal.
[9] D. Stevenson,et al. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. , 2003, The Journal of allergy and clinical immunology.
[10] N. Higashi,et al. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin‐intolerant asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[11] G. Town,et al. Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. , 2002, Free radical biology & medicine.
[12] L. Mastalerz,et al. Myocardial ischemia possibly mediated by cysteinyl leukotrienes. , 2002, The Journal of allergy and clinical immunology.
[13] J. Heinecke,et al. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. , 2002, Analytical biochemistry.
[14] P. Weller,et al. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. , 2001, The Journal of allergy and clinical immunology.
[15] A. Sampson,et al. Leukotrienes in cardiovascular disease , 2001 .
[16] S. Hazen,et al. Eosinophils Are a Major Source of Nitric Oxide-Derived Oxidants in Severe Asthma: Characterization of Pathways Available to Eosinophils for Generating Reactive Nitrogen Species4 , 2001, The Journal of Immunology.
[17] J. Palmblad,et al. Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor. , 2001, European journal of biochemistry.
[18] R. Robbins,et al. Methotrexate stimulates lung fibroblasts and epithelial cells to release eosinophil chemotactic activity. , 2001, The Journal of rheumatology.
[19] S. Hazen,et al. Myeloperoxidase-generated oxidants and atherosclerosis. , 2000, Free radical biology & medicine.
[20] S. Hazen,et al. Eosinophils generate brominating oxidants in allergen-induced asthma. , 2000, The Journal of clinical investigation.
[21] B. Halliwell,et al. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. , 2000, The Biochemical journal.
[22] S. Holgate. The epidemic of allergy and asthma , 1999, Nature.
[23] R J Falk,et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) , 1999, American journal of clinical pathology.
[24] S. Hazen,et al. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. , 1999, Biochemistry.
[25] S. Kobayashi,et al. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. , 1998, Arthritis and rheumatism.
[26] S. L. Hazen,et al. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. , 1997, The Journal of clinical investigation.
[27] M. Kumlin. Measurements of leukotrienes in the urine: strategies and applications , 1997, Allergy.
[28] S. L. Hazen,et al. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. , 1996, The Journal of clinical investigation.
[29] B. Haynes,et al. Pathogenic mechanisms of vessel damage in vasculitis syndromes. , 1995, Rheumatic diseases clinics of North America.
[30] W. Lehmann,et al. Increased generation of cysteinyl leukotrienes in Kawasaki disease. , 1995, Archives of disease in childhood.
[31] P. Bozeman,et al. Oxidation of Bromide by the Human Leukocyte Enzymes Myeloperoxidase and Eosinophil Peroxidase , 1995, The Journal of Biological Chemistry.
[32] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[33] P. Weller,et al. Eosinophils: structure and functions. , 1994, Current opinion in immunology.
[34] T. Haahtela,et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.
[35] C. Serhan,et al. Angioplasty Triggers Intracoronary Leukotrienes and Lipoxin A4: Impact of Aspirin Therapy , 1992, Circulation.
[36] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[37] P. Tugwell,et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.
[38] R. Falk,et al. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. , 1989, The American journal of pathology.
[39] M. Tomonaga,et al. Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. , 1989, The Journal of biological chemistry.
[40] L. Pease,et al. Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family , 1989, The Journal of experimental medicine.
[41] R. Falk,et al. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.
[42] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[43] S. Weiss,et al. Brominating oxidants generated by human eosinophils. , 1986, Science.
[44] R. Matthay,et al. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. , 1986, The American review of respiratory disease.
[45] P. Venge,et al. Human eosinophil peroxidase: purification and characterization. , 1985, Journal of immunology.
[46] T. H. The,et al. AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.
[47] G. Hughes,et al. Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg‐Strauss Syndrome , 1984, Medicine.
[48] R. Lehrer,et al. Assessment of chlorination by human neutrophils , 1983, Nature.
[49] S. Weiss,et al. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. , 1982, The Journal of clinical investigation.
[50] W. Henderson,et al. Bactericidal activity of eosinophil peroxidase. , 1980, Journal of immunology.
[51] M. Taniguchi,et al. Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[52] L. Guillevin,et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. , 1999, Medicine.
[53] R. Matthay,et al. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. , 1986, The American review of respiratory disease.
[54] R. Locksley,et al. Oxidative response of phagocytes to parasite invasion. , 1983, Ciba Foundation symposium.